跳至主要内容
临床试验/JPRN-UMIN000049038
JPRN-UMIN000049038已完成未知

Burden in quality of life (QOL), work productivity and healthcare cost for caregivers of patients with schizophrenia, depression, Alzheimer's disease, dementia and stroke - Burden in quality of life (QOL), work productivity and healthcare cost for caregivers of patients with schizophrenia, depression, Alzheimer's disease, dementia and stroke

Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department0 个研究点目标入组 50,117 人开始时间: 2022年9月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50,117

研究概览

简要总结

The result showed that all caregiver groups had significantly higher CCI than non-caregivers. Caregivers of depression were younger, and a larger proportion of them were currently employed.

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • - Respondents who did not provide sufficient answers are excluded from the study. - For respondents who participated in both NHWS 2016 and 2018, only the most recent response (NHWS 2018) will be collected and the response from NHWS 2016 will be excluded.

研究者

发起方
Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department

相似试验